• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HILL-ROM BATESVILLE PROGRESSA FRAME; BED, AC-POWERED ADJUSTABLE HOSPITAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HILL-ROM BATESVILLE PROGRESSA FRAME; BED, AC-POWERED ADJUSTABLE HOSPITAL Back to Search Results
Model Number P7500A001475
Device Problems Use of Device Problem (1670); Insufficient Information (3190)
Patient Problem Pressure Sores (2326)
Event Date 04/11/2023
Event Type  Injury  
Event Description
The customer contributes an upsurge of pressure injuries ranging from stage 1 to stage 3 to the use of the progressa bed.This report was filed in our complaint handling system as complaint #(b)(4).
 
Manufacturer Narrative
It was initially reported that the customer contributes an upsurge in the presence of pressure injures to the use of the progressa bed.Follow-up with the customer determined that the patient associated with this bed ((b)(6)) was reported to have stage 2 sacrum, stage 3 left buttock, stage 1 right buttock ((b)(6) 2023), stage 2 coude ((b)(6) 2023) and stage 3 elbow ((b)(6) 2023) pressure injuries.Medical intervention was not reported.Additionally, specific details of the event including clarification if the associated pressure injury were preexisting, or the patient¿s medical history were not provided.The progressa bed is intended to be used to treat or prevent pulmonary or other complications associated with immobility, pressure ulcers, or for any other use where medical benefits may be derived from either continuous lateral rotation therapy or percussion/vibration therapy.Additionally, the instructions for use (ifu) states the therapy surface is not a substitute for good nursing practices.Therapy modes should be used in conjunction with good assessment and protocol.Failure to follow good nursing practices may result in patient harm.The development of pressure injuries is multifactorial and cannot only be attributed to the performance of the surface or the progressa bed.Pressure injuries can develop within 2-6 hours when capillaries supplying the skin and subcutaneous tissues are compressed, causing an obstruction in blood flow, which ultimately leads to tissue necrosis.Position changes are key to pressure injury prevention and treatment.These changes need to be frequent, repositioning needs to avoid stress on the skin, and body positions need to minimize the risk of pressure on vulnerable areas.Prevention of pressure injuries involves a multidisciplinary approach including rapid identification of at-risk individuals such as those with diabetes, incontinence, impaired mobility, peripheral vascular disease, etc.And exercising a vigilant prevention protocol consisting of skincare, nutritional assessment reducing mechanical load, and utilizing support surfaces.Additionally, the device instructions for use (ifu) states the therapy surface is not a substitute for good nursing practice and the device therapy modes should be used in conjunction with good assessment and protocol.Stage 1 pressure injury is characterized by reddening of the skin that does not blanch when touched/pressed.Partial-thickness skin loss no deeper than the dermis and can include intact or ruptured blisters.A stage 2 pressure injury is characterized by partial-thickness skin loss no deeper than the dermis and can include intact or ruptured blisters.Stage 1 and stage 2 pressure injuries can heal very rapidly therefore treatment is focused on nutrition to support wound healing and keeping the area protected/covered and clean.A stage 3 pressure injury is categorized as full-thickness tissue loss.Subcutaneous fat may be visible, but bone, tendon or muscle are not exposed.A stage 3 pressure injury often requires medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure and therefore meets the definition of a serious injury.At this time, the device inspection is pending, as the reported bed remains in patient use and the customer has not made the device available for inspection.If any additional relevant information is identified following completion of the investigation, the additional relevant information will be submitted in a supplemental report.
 
Manufacturer Narrative
The customer contributes an upsurge of pressure injuries ranging from stage 1 to stage 3 to the use of the progressa bed.Specific details of the event including clarification if the associated pressure injury were preexisting, the medical treatment provided for the pressure injury, the patient¿s medical history, accessory devices utilized, and facilities positioning protocols were not provided.This report is in reference to a possible reportable malfunction for the progressa bed with the serial: (b)(6).Follow-up with the customer determined that the patient associated with this bed (b)(6) was reported to have stage 2 sacrum, stage 3 left buttock, stage 1 right buttock on (b)(6) 2023), stage 2 coude on (b)(6) 2023) and stage 3 elbow on (b)(6) 2023) pressure injuries.Medical intervention was not reported.Additionally, specific details of the event including clarification if the associated pressure injury were preexisting, or the patient¿s medical history were not provided.The hillrom technician thoroughly evaluated the bed from the event reported by the customer.It was confirmed that the bed was functioning correctly and in accordance with the technical manual: no error codes.All values are within the ranges of the technical documentation.The pressures measured were in compliance with the expectations.No malfunction, the bed was performing within specifications.The progressa bed is intended to be used to treat or prevent pulmonary or other complications associated with immobility, pressure ulcers, or for any other use where medical benefits may be derived from either continuous lateral rotation therapy or percussion/vibration therapy.Additionally, the instructions for use (ifu) states the therapy surface is not a substitute for good nursing practices.Therapy modes should be used in conjunction with good assessment and protocol.Failure to follow good nursing practices may result in patient harm.The development of pressure injuries is multifactorial and cannot only be attributed to the performance of the surface or the progressa bed.Pressure injuries can develop within 2-6 hours when capillaries supplying the skin and subcutaneous tissues are compressed, causing an obstruction in blood flow, which ultimately leads to tissue necrosis.Position changes are key to pressure injury prevention and treatment.These changes need to be frequent, repositioning needs to avoid stress on the skin, and body positions need to minimize the risk of pressure on vulnerable areas.Prevention of pressure injuries involves a multidisciplinary approach including rapid identification of at-risk individuals such as those with diabetes, incontinence, impaired mobility, peripheral vascular disease, etc.And exercising a vigilant prevention protocol consisting of skincare, nutritional assessment reducing mechanical load, and utilizing support surfaces.Additionally, the device instructions for use (ifu) states the therapy surface is not a substitute for good nursing practice and the device therapy modes should be used in conjunction with good assessment and protocol.A stage 1 pressure injury is characterized by reddening of the skin that does not blanch when touched/pressed.Partial-thickness skin loss no deeper than the dermis and can include intact or ruptured blisters.A stage 2 pressure injury is characterized by partial-thickness skin loss no deeper than the dermis and can include intact or ruptured blisters.Stage 1 and stage 2 pressure injuries can heal very rapidly therefore treatment is focused on nutrition to support wound healing and keeping the area protected/covered and clean.A stage 3 pressure injury is categorized as full-thickness tissue loss.Subcutaneous fat may be visible, but bone, tendon or muscle are not exposed.A stage 3 pressure injury often requires medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure and therefore meets the definition of a serious injury.In this event, based on the report of a stage 3 pressure injury, indicates the occurrence of a serious injury.The root cause of the reported pressure injuries is unknown due to the sparsity of details provided.The inspection of the device notes the bed to be functioning as designed and noted pressure to be within appropriate range, thus ruling out a device malfunction.
 
Event Description
The customer contributes an upsurge of pressure injuries ranging from stage 1 to stage 3 to the use of the progressa bed.This report was filed in our complaint handling system as complaint#: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROGRESSA FRAME
Type of Device
BED, AC-POWERED ADJUSTABLE HOSPITAL
Manufacturer (Section D)
HILL-ROM BATESVILLE
1069 state route 46 east
batesville IN 47006
Manufacturer Contact
maritza valencia
1069 state route 46 east
batesville, IN 47006
8129310130
MDR Report Key16889671
MDR Text Key314806072
Report Number1824206-2023-00376
Device Sequence Number1
Product Code FNL
Combination Product (y/n)N
Reporter Country CodeFR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type User Facility,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 09/14/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/08/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Model NumberP7500A001475
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Date Manufacturer Received04/11/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/13/2020
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Other;
-
-